Portfolio (Quarterly)
Guide ↗
NAN FUNG TRINITY (HK) LTD
· CIK 0001781880| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | — | SOLENO THERAPEUTICS INC | — | 123,850.0 | $5.7M | 0.45% | NEW | — | $46.30 | — |
| 62 | REPL | REPLIMUNE GROUP INC | Healthcare | 575,527.0 | $5.6M | 0.44% | NEW | — | $9.72 | -51.6% |
| 63 | ESRT | EMPIRE ST RLTY TR INC | Real Estate | 801,300.0 | $5.2M | 0.41% | NEW | — | $6.52 | -11.5% |
| 64 | — | ABEONA THERAPEUTICS INC | — | 956,770.0 | $5.0M | 0.40% | NEW | — | $5.27 | — |
| 65 | VNO | VORNADO RLTY TR | Real Estate | 143,800.0 | $4.8M | 0.38% | NEW | — | $33.28 | +0.1% |
| 66 | ZLAB | ZAI LAB LTD | Healthcare | 269,975.0 | $4.8M | 0.38% | NEW | — | $17.64 | +6.0% |
| 67 | BAH | BOOZ ALLEN HAMILTON HLDG COR | Industrials | 49,500.0 | $4.2M | 0.33% | NEW | — | $84.36 | -4.0% |
| 68 | — | AVALO THERAPEUTICS INC | — | 189,000.0 | $3.4M | 0.27% | NEW | — | $18.16 | — |
| 69 | QURE | UNIQURE NV | Healthcare | 115,494.0 | $2.8M | 0.22% | NEW | — | $23.93 | +5.2% |
| 70 | DOC | HEALTHPEAK PROPERTIES INC | Real Estate | 165,064.0 | $2.7M | 0.21% | NEW | — | $16.08 | +23.6% |
| 71 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 154,522.0 | $2.5M | 0.20% | NEW | — | $16.15 | +65.9% |
| 72 | IDV | ISHARES TR | — | 53,500.0 | $2.1M | 0.17% | NEW | — | $39.45 | +13.4% |
| 73 | SPYD | SPDR SERIES TRUST | — | 45,600.0 | $2.0M | 0.16% | NEW | — | $43.25 | +10.3% |
| 74 | — | CLIMB BIO INC | — | 463,654.0 | $1.9M | 0.15% | NEW | — | $4.00 | — |
| 75 | GERN | GERON CORP | Healthcare | 1,373,550.0 | $1.8M | 0.14% | NEW | — | $1.32 | -4.5% |
| 76 | — | DBV TECHNOLOGIES S A | — | 37,095.0 | $711K | 0.06% | NEW | — | $19.17 | — |
| 77 | RXRX | RECURSION PHARMACEUTICALS IN | Healthcare | 69,323.0 | $284K | 0.02% | NEW | — | $4.09 | -22.5% |
| 78 | ALXO | ALX ONCOLOGY HLDGS INC | Healthcare | 41,950.0 | $47K | 0.00% | NEW | — | $1.13 | +73.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
27.9%
Technology
22.1%
Communication Services
14.4%
Basic Materials
11.4%
Consumer Cyclical
10.1%
Real Estate
7.1%
Industrials
4.2%
Financial Services
1.8%
Consumer Defensive
1.0%